Your browser doesn't support javascript.
loading
Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui, Wided; Arnold, Robert D; Cummings, Brian S.
Afiliação
  • Najahi-Missaoui W; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA.
  • Arnold RD; Department of Drug Discovery & Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Cummings BS; Interdisciplinary Toxicology Program, University of Georgia, Athens, GA 30602, USA.
Int J Mol Sci ; 22(1)2020 Dec 31.
Article em En | MEDLINE | ID: mdl-33396561
ABSTRACT
The field of nanotechnology has grown over the last two decades and made the transition from the benchtop to applied technologies. Nanoscale-sized particles, or nanoparticles, have emerged as promising tools with broad applications in drug delivery, diagnostics, cosmetics and several other biological and non-biological areas. These advances lead to questions about nanoparticle safety. Despite considerable efforts to understand the toxicity and safety of these nanoparticles, many of these questions are not yet fully answered. Nevertheless, these efforts have identified several approaches to minimize and prevent nanoparticle toxicity to promote safer nanotechnology. This review summarizes our current knowledge on nanoparticles, their toxic effects, their interactions with mammalian cells and finally current approaches to minimizing their toxicity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Sistemas de Liberação de Medicamentos / Nanotecnologia / Nanopartículas Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Sistemas de Liberação de Medicamentos / Nanotecnologia / Nanopartículas Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article